Drug information is important in highly regulated world of pharmaceuticals because use of incorrect information may result in an injurious outcome. The Structured Product Labeling (SPL) is one of the basic instruments that the U.S. Food and Drug Administration (FDA) employs in this undertaking.
What is Patient Information Leaflet (PIL)?
Understanding your medication is as important as taking it correctly. One of the key tools that help patients make informed decisions about their health is the Patient Information Leaflet (PIL). Chances are, whether you are prescribed medication or purchase an over-the-counter product, it will have a PIL.Accuracy and compliance are the key in the pharmaceutical profession and particularly when they present regulatory materials to health authorities. The simplest formatting mistake might mean rejection or subject to expensive delays. Submission eValidation guarantees that your electronic submissions are completed in all technical and structural compliance prior to sending regulators.
What is Submission Level Publishing?
Regulatory submissions in the pharmaceutical industry are key processes that will dictate whether a drug or a medical product will make it to the market. In the setting of highly demanding regulatory requirements and complicated documentation, there has been the development of submission level publishing as a very important process to guarantee accuracy, compliance and efficiency in the processing of producing and providing regulatory dossiers.
The pharmaceutical industry depends on clear and precise information on medicinal products to establish their safe and effective use. The most important of regulatory documents used in this capacity is the Summary of Product Characteristics (SmPC). The document serves as the foundation of communication among pharmaceutical companies, regulatory authorities and health professionals.